+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bronchodilators Market by Mechanism Of Action (Anticholinergics, Beta-2 Agonists, Combination Agents), Product Type (Long-Acting, Short-Acting), Indication, Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Bronchodilators Market by Mechanism Of Action (Anticholinergics, Beta-2 Agonists, Combination Agents), Product Type (Long-Acting, Short-Acting), Indication, Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Sale

Bronchodilators Market by Mechanism Of Action (Anticholinergics, Beta-2 Agonists, Combination Agents), Product Type (Long-Acting, Short-Acting), Indication, Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6084105
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The bronchodilators market is evolving rapidly as healthcare systems worldwide adapt to higher respiratory disease burdens, expanding treatment options, and emerging digital health technologies. Stakeholders face shifting regulations, technology advances, and new supply chain challenges that make strategic insights essential for confident investment and operational planning.

Market Snapshot: Bronchodilators Market Growth and Outlook

The bronchodilators market grew from USD 19.20 billion in 2024 to USD 20.42 billion in 2025. It is expected to continue growing at a CAGR of 6.23%, reaching USD 27.61 billion by 2030. This progression reflects a combination of increased prevalence of asthma and chronic obstructive pulmonary disease (COPD), a strong pipeline of innovative formulations, and the adoption of smart inhaler technologies. Evolving reimbursement policies and shifting patient demographics also play a significant role in market expansion. Stakeholders must closely monitor these drivers to inform product portfolios and regional expansion plans.

Scope & Segmentation

This report meticulously assesses the bronchodilators market by in-depth segmentation to provide clarity for commercial, product, and regional strategies.

  • Mechanism of Action: Anticholinergics, beta-2 agonists, and combination agents, each with distinct efficacy and use cases for chronic and acute symptoms.
  • Product Type: Long-acting and short-acting bromchodilators, impacting treatment duration and patient adherence.
  • Indication: Covers both asthma and COPD, addressing different clinical pathways and population needs.
  • Route of Administration: Includes inhalation (dry powder, metered-dose, soft mist devices), injectable, nebulization (jet, ultrasonic), and oral administration.
  • Distribution Channel: Hospital pharmacies, retail outlets, and online pharmacies shaping access and pricing transparency.
  • End User: Hospitals, clinics, and home care settings, each with unique device durability and support requirements.
  • Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina), EMEA (featuring UK, Germany, France, Russia, Italy, Spain, and several Middle Eastern and African countries), and Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asia).
  • Key Players: Companies such as GlaxoSmithKline plc, AstraZeneca plc, Boehringer Ingelheim International GmbH, Novartis AG, and others contribute through robust portfolios, alliances, and global reach.
  • Technologies: Focus on advanced inhalation devices (soft mist, dry powder), connected inhalers, and biosimilar development.

Key Takeaways for Decision-Makers

  • Rising rates of respiratory diseases and an aging population worldwide are amplifying demand for both maintenance and rescue therapies.
  • Technological advances in inhaler platforms and real-time digital adherence tools are reshaping patient engagement and data collection.
  • Strategic partnerships between large pharmaceutical companies and biotech innovators foster agile research, pipeline diversification, and risk-sharing.
  • Regulatory frameworks are rapidly evolving, creating faster approval pathways for generics and biosimilars and requiring proactive compliance planning.
  • Regional market dynamics differ substantially based on healthcare infrastructure, reimbursement environments, and regulatory regimes, with Asia-Pacific poised for fast adoption driven by environmental and demographic factors.
  • Sustainability and environmental stewardship, including device recycling and eco-friendly packaging, are emerging priorities among industry leaders.

Tariff Impact on Supply Chains and Pricing Structures

Recent tariff adjustments in the United States have led to notable shifts in supply chain strategies among bronchodilator manufacturers. Duties on imported raw materials have encouraged diversification in sourcing and enhanced local production investments. As a result, organizations are navigating increased lead time volatility and closely managing inventory to minimize market disruption. Pricing has been affected, prompting discussions with payers on new reimbursement and risk-sharing models. Companies are increasingly exploring alternative manufacturing hubs outside North America to bolster resiliency and sustain market access.

Methodology & Data Sources

Analysis is grounded in a blend of primary research, including interviews with clinicians and commercial executives, alongside secondary data sources such as regulatory filings, peer-reviewed journals, and proprietary industry databases. Scenario modeling and sensitivity analyses were employed to account for market uncertainties, ensuring data integrity and actionable intelligence for stakeholders.

Why This Report Matters

  • Empowers senior executives with relevant, actionable insights for evidence-based investment, product planning, and risk management.
  • Delivers a nuanced perspective on technology adoption, market access evolution, and geographic growth opportunities for informed decision-making.
  • Supports supply chain optimization, competitive differentiation, and regulatory preparedness in a high-growth therapeutic area.

Conclusion

The bronchodilators market continues to transform through scientific, technological, and competitive shifts. Strategic insights from this report enable stakeholders to anticipate change, refine commercial strategies, and advance optimized respiratory care globally.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of digital inhaler sensors enabling real-time patient adherence monitoring
5.2. Growth of nebulizer-based bronchodilator therapies for pediatric and geriatric asthma management
5.3. Increasing investment in dual bronchodilator combination therapies targeting COPD exacerbations
5.4. Expansion of generic inhaled bronchodilators driving cost-effective respiratory care options worldwide
5.5. Development of ultra-long-acting bronchodilators offering 24-hour symptom relief for chronic airway diseases
5.6. Integration of artificial intelligence in bronchodilator treatment plans for personalized dosage optimization
5.7. Regulatory approvals and pipeline advancements in novel bronchodilator drug-device combination products
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bronchodilators Market, by Mechanism Of Action
8.1. Introduction
8.2. Anticholinergics
8.2.1. Long-Acting Muscarinic Antagonists
8.2.2. Short-Acting Muscarinic Antagonists
8.3. Beta-2 Agonists
8.3.1. Long-Acting Beta-2 Agonists
8.3.2. Short-Acting Beta-2 Agonists
8.4. Combination Agents
8.4.1. ICS/LABA Combinations
8.4.2. LABA/LAMA Combinations
9. Bronchodilators Market, by Product Type
9.1. Introduction
9.2. Long-Acting
9.3. Short-Acting
10. Bronchodilators Market, by Indication
10.1. Introduction
10.2. Asthma
10.3. COPD
11. Bronchodilators Market, by Route Of Administration
11.1. Introduction
11.2. Inhalation
11.2.1. Dry Powder Inhaler
11.2.2. Metered-Dose Inhaler
11.2.3. Soft Mist Inhaler
11.3. Injectable
11.4. Nebulization
11.4.1. Jet Nebulization
11.4.2. Ultrasonic Nebulization
11.5. Oral
12. Bronchodilators Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
13. Bronchodilators Market, by End User
13.1. Introduction
13.2. Clinics
13.3. Home Care
13.4. Hospitals
14. Americas Bronchodilators Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Bronchodilators Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Bronchodilators Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. GlaxoSmithKline plc
17.3.2. AstraZeneca plc
17.3.3. Boehringer Ingelheim International GmbH
17.3.4. Novartis AG
17.3.5. Teva Pharmaceutical Industries Ltd
17.3.6. Viatris Inc.
17.3.7. Chiesi Farmaceutici S.p.A
17.3.8. Cipla Limited
17.3.9. Sunovion Pharmaceuticals Inc.
17.3.10. Hikma Pharmaceuticals PLC
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BRONCHODILATORS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BRONCHODILATORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BRONCHODILATORS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BRONCHODILATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BRONCHODILATORS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BRONCHODILATORS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BRONCHODILATORS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BRONCHODILATORS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BRONCHODILATORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BRONCHODILATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BRONCHODILATORS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BRONCHODILATORS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BRONCHODILATORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BRONCHODILATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BRONCHODILATORS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BRONCHODILATORS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. BRONCHODILATORS MARKET: RESEARCHAI
FIGURE 28. BRONCHODILATORS MARKET: RESEARCHSTATISTICS
FIGURE 29. BRONCHODILATORS MARKET: RESEARCHCONTACTS
FIGURE 30. BRONCHODILATORS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BRONCHODILATORS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BRONCHODILATORS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BRONCHODILATORS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BRONCHODILATORS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BRONCHODILATORS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BRONCHODILATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BRONCHODILATORS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BRONCHODILATORS MARKET SIZE, BY LONG-ACTING MUSCARINIC ANTAGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BRONCHODILATORS MARKET SIZE, BY LONG-ACTING MUSCARINIC ANTAGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BRONCHODILATORS MARKET SIZE, BY SHORT-ACTING MUSCARINIC ANTAGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BRONCHODILATORS MARKET SIZE, BY SHORT-ACTING MUSCARINIC ANTAGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BRONCHODILATORS MARKET SIZE, BY LONG-ACTING BETA-2 AGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BRONCHODILATORS MARKET SIZE, BY LONG-ACTING BETA-2 AGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BRONCHODILATORS MARKET SIZE, BY SHORT-ACTING BETA-2 AGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BRONCHODILATORS MARKET SIZE, BY SHORT-ACTING BETA-2 AGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BRONCHODILATORS MARKET SIZE, BY ICS/LABA COMBINATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BRONCHODILATORS MARKET SIZE, BY ICS/LABA COMBINATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BRONCHODILATORS MARKET SIZE, BY LABA/LAMA COMBINATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BRONCHODILATORS MARKET SIZE, BY LABA/LAMA COMBINATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BRONCHODILATORS MARKET SIZE, BY LONG-ACTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BRONCHODILATORS MARKET SIZE, BY LONG-ACTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BRONCHODILATORS MARKET SIZE, BY SHORT-ACTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BRONCHODILATORS MARKET SIZE, BY SHORT-ACTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BRONCHODILATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BRONCHODILATORS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BRONCHODILATORS MARKET SIZE, BY ASTHMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BRONCHODILATORS MARKET SIZE, BY COPD, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BRONCHODILATORS MARKET SIZE, BY COPD, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BRONCHODILATORS MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BRONCHODILATORS MARKET SIZE, BY INHALATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BRONCHODILATORS MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BRONCHODILATORS MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BRONCHODILATORS MARKET SIZE, BY METERED-DOSE INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BRONCHODILATORS MARKET SIZE, BY METERED-DOSE INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BRONCHODILATORS MARKET SIZE, BY SOFT MIST INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BRONCHODILATORS MARKET SIZE, BY SOFT MIST INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BRONCHODILATORS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BRONCHODILATORS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BRONCHODILATORS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BRONCHODILATORS MARKET SIZE, BY JET NEBULIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BRONCHODILATORS MARKET SIZE, BY JET NEBULIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BRONCHODILATORS MARKET SIZE, BY ULTRASONIC NEBULIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BRONCHODILATORS MARKET SIZE, BY ULTRASONIC NEBULIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BRONCHODILATORS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BRONCHODILATORS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BRONCHODILATORS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BRONCHODILATORS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BRONCHODILATORS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BRONCHODILATORS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BRONCHODILATORS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BRONCHODILATORS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BRONCHODILATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BRONCHODILATORS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BRONCHODILATORS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BRONCHODILATORS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BRONCHODILATORS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BRONCHODILATORS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BRONCHODILATORS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS BRONCHODILATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS BRONCHODILATORS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS BRONCHODILATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS BRONCHODILATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS BRONCHODILATORS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES BRONCHODILATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES BRONCHODILATORS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES BRONCHODILATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES BRONCHODILATORS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES BRONCHODILATORS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 135. CANADA BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 136. CANADA BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 137. CANADA BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2024 (USD MILLION)
TABLE 138. CANADA BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2025-2030 (USD MILLION)
TABLE 139. CANADA BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2024 (USD MILLION)
TABLE 140. CANADA BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2025-2030 (USD MILLION)
TABLE 141. CANADA BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2024 (USD MILLION)
TABLE 142. CANADA BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2025-2030 (USD MILLION)
TABLE 143. CANADA BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 144. CANADA BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 145. CANADA BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 146. CANADA BRONCHODILATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 147. CANADA BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 148. CANADA BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 149. CANADA BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 150. CANADA BRONCHODILATORS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 151. CANADA BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2024 (USD MILLION)
TABLE 152. CANADA BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2025-2030 (USD MILLION)
TABLE 153. CANADA BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. CANADA BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. CANADA BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. CANADA BRONCHODILATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. MEXICO BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 158. MEXICO BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 159. MEXICO BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2024 (USD MILLION)
TABLE 160. MEXICO BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2025-2030 (USD MILLION)
TABLE 161. MEXICO BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2024 (USD MILLION)
TABLE 162. MEXICO BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2025-2030 (USD MILLION)
TABLE 163. MEXICO BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2024 (USD MILLION)
TABLE 164. MEXICO BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2025-2030 (USD MILLION)
TABLE 165. MEXICO BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. MEXICO BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. MEXICO BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 168. MEXICO BRONCHODILATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 169. MEXICO BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 170. MEXICO BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 171. MEXICO BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 172. MEXICO BRONCHODILATORS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 173. MEXICO BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2024 (USD MILLION)
TABLE 174. MEXICO BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2025-2030 (USD MILLION)
TABLE 175. MEXICO BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. MEXICO BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. MEXICO BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. MEXICO BRONCHODILATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL BRONCHODILATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL BRONCHODILATORS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL BRONCHODILATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA BRONCHODILATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA BRONCHODILATORS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA BRONCHODILATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. GERMANY BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 270. GERMANY BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 271. GERMANY BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2024 (USD MILLION)
TABLE 272. GERMANY BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2025-2030 (USD MILLION)
TABLE 273. GERMANY BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2024 (USD MILLION)
TABLE 274. GERMANY BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2025-2030 (USD MILLION)
TABLE 275. GERMANY BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2024 (USD MILLION)
TABLE 276. GERMANY BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2025-2030 (USD MILLION)
TABLE 277. GERMANY BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. GERMANY BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. GERMANY BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 280. GERMANY BRONCHODILATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 281. GERMANY BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 282. GERMANY BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 283. GERMANY BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 284. GERMANY BRONCHODILATORS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 285. GERMANY BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2024 (USD MILLION)
TABLE 286. GERMANY BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2025-2030 (USD MILLION)
TABLE 287. GERMANY BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. GERMANY BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. GERMANY BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. GERMANY BRONCHODILATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. FRANCE BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 292. FRANCE BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 293. FRANCE BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2024 (USD MILLION)
TABLE 294. FRANCE BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2025-2030 (USD MILLION)
TABLE 295. FRANCE BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2024 (USD MILLION)
TABLE 296. FRANCE BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2025-2030 (USD MILLION)
TABLE 297. FRANCE BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2024 (USD MILLION)
TABLE 298. FRANCE BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2025-2030 (USD MILLION)
TABLE 299. FRANCE BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 300. FRANCE BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 301. FRANCE BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 302. FRANCE BRONCHODILATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 303. FRANCE BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 304. FRANCE BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 305. FRANCE BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 306. FRANCE BRONCHODILATORS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 307. FRANCE BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2024 (USD MILLION)
TABLE 308. FRANCE BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2025-2030 (USD MILLION)
TABLE 309. FRANCE BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 310. FRANCE BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 311. FRANCE BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. FRANCE BRONCHODILATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 315. RUSSIA BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2024 (USD MILLION)
TABLE 316. RUSSIA BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2025-2030 (USD MILLION)
TABLE 317. RUSSIA BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2024 (USD MILLION)
TABLE 318. RUSSIA BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2025-2030 (USD MILLION)
TABLE 319. RUSSIA BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2024 (USD MILLION)
TABLE 320. RUSSIA BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2025-2030 (USD MILLION)
TABLE 321. RUSSIA BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 322. RUSSIA BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 323. RUSSIA BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 324. RUSSIA BRONCHODILATORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 325. RUSSIA BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 326. RUSSIA BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 327. RUSSIA BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 328. RUSSIA BRONCHODILATORS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 329. RUSSIA BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2024 (USD MILLION)
TABLE 330. RUSSIA BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2025-2030 (USD MILLION)
TABLE 331. RUSSIA BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 332. RUSSIA BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 333. RUSSIA BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 334. RUSSIA BRONCHODILATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 335. ITALY BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 336. ITALY BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 337. ITALY BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2024 (USD MILLION)
TABLE 338. ITALY BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2025-2030 (USD MILLION)
TABLE 339. ITALY BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2024 (USD MILLION)
TABLE 340. ITALY BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2025-2030 (USD MILLION)
TABLE 341. ITALY BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2024 (USD MILLION)
TABLE 342. ITALY BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2025-2030 (USD MILLION)
TABLE 343. ITALY BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 344. ITALY BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 345. ITALY BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 346. ITALY BRONCHODILATORS MARKET

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Bronchodilators market report include:
  • GlaxoSmithKline plc
  • AstraZeneca plc
  • Boehringer Ingelheim International GmbH
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd
  • Viatris Inc.
  • Chiesi Farmaceutici S.p.A
  • Cipla Limited
  • Sunovion Pharmaceuticals Inc.
  • Hikma Pharmaceuticals PLC

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 20.42 Billion
Forecasted Market Value ( USD ) by 2030 $ 27.61 Billion
Compound Annual Growth Rate6.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Bronchodilators - Global Strategic Business Report - Product Image

Bronchodilators - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Bronchodilators: Market Share, and Growth Analysis by Product Type (Short-Acting Beta Agonists, Long-Acting Beta Agonists, Anticholinergics, Methylxanthines), Application, End User, Technology - Product Image

Bronchodilators: Market Share, and Growth Analysis by Product Type (Short-Acting Beta Agonists, Long-Acting Beta Agonists, Anticholinergics, Methylxanthines), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Bronchodilators Market Report 2025 - Product Image

Bronchodilators Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Bronchitis Treatment Market by Treatment Type (Herbal Supplements, Over The Counter, Prescription), Drug Class (Antibiotics, Bronchodilators, Corticosteroids), Route Of Administration, Distribution Channel, End User, Age Group, Product Form - Global Forecast 2025-2030 - Product Image

Bronchitis Treatment Market by Treatment Type (Herbal Supplements, Over The Counter, Prescription), Drug Class (Antibiotics, Bronchodilators, Corticosteroids), Route Of Administration, Distribution Channel, End User, Age Group, Product Form - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Bronchitis Drugs Market by Drug Type (Antibiotics, Bronchodilators, Corticosteroids), Route Of Administration (Inhalation, Injection, Oral), Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Bronchitis Drugs Market by Drug Type (Antibiotics, Bronchodilators, Corticosteroids), Route Of Administration (Inhalation, Injection, Oral), Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From

About the Market

The Bronchodilator market is composed of inhalers and nebulisers, both of which are used to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Inhalers are handheld devices that deliver medication directly to the lungs in the form of a mist or spray. Nebulisers are larger machines that convert liquid medication into a fine mist that can be inhaled. Both inhalers and nebulisers are used to deliver bronchodilators, which are medications that relax the muscles in the airways and make it easier to breathe. Inhalers are the most commonly used form of bronchodilator delivery, as they are more convenient and cost-effective than nebulisers. Inhalers come in a variety of forms, including metered dose inhalers (MDIs), dry powder inhalers (DPIs), and soft mist inhalers (SMIs). Nebulisers are typically used for more severe cases of respiratory conditions, as they can deliver a higher dose of medication than inhalers. Some of the companies in the Bronchodilator market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, and Merck. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.